Stone Run Capital, LLC Bio Techne Corp Call Options Transaction History
Stone Run Capital, LLC
- $250 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TECH
# of Institutions
604Shares Held
153MCall Options Held
171KPut Options Held
56.9K-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.36 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY15MShares$1.12 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.53MShares$637 Million0.07% of portfolio
-
State Street Corp Boston, MA6.3MShares$471 Million0.02% of portfolio
-
Bamco Inc New York, NY4.78MShares$357 Million1.0% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $2.93B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...